GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 355 filers reported holding GLOBUS MED INC in Q2 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $491 | +77.9% | 9,895 | +113.6% | 0.02% | +92.3% |
Q2 2023 | $276 | +16.5% | 4,633 | +10.8% | 0.01% | +8.3% |
Q1 2023 | $237 | -24.8% | 4,182 | -1.5% | 0.01% | -25.0% |
Q4 2022 | $315 | -99.9% | 4,246 | +2.1% | 0.02% | +14.3% |
Q3 2022 | $248,000 | +4.2% | 4,159 | -1.7% | 0.01% | +16.7% |
Q2 2022 | $238,000 | -25.4% | 4,232 | -2.3% | 0.01% | -14.3% |
Q1 2022 | $319,000 | -10.9% | 4,330 | -12.6% | 0.01% | 0.0% |
Q4 2021 | $358,000 | -20.3% | 4,954 | -15.4% | 0.01% | -26.3% |
Q3 2021 | $449,000 | -8.2% | 5,855 | -7.1% | 0.02% | -13.6% |
Q2 2021 | $489,000 | +20.4% | 6,305 | -4.3% | 0.02% | +4.8% |
Q1 2021 | $406,000 | -21.0% | 6,587 | -16.4% | 0.02% | -25.0% |
Q4 2020 | $514,000 | +51.6% | 7,878 | +14.9% | 0.03% | +27.3% |
Q3 2020 | $339,000 | +5.0% | 6,854 | +1.3% | 0.02% | -8.3% |
Q2 2020 | $323,000 | +24.2% | 6,769 | +10.6% | 0.02% | +9.1% |
Q1 2020 | $260,000 | -34.2% | 6,119 | -8.8% | 0.02% | -18.5% |
Q4 2019 | $395,000 | – | 6,711 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 908,953 | $59,282,000 | 5.54% |
Sterling Investment Advisors, Ltd. | 234,623 | $15,302,000 | 5.20% |
Next Capital Management LLC | 111,098 | $7,246,000 | 5.10% |
Godshalk Welsh Capital Management, Inc. | 77,085 | $5,027,000 | 3.71% |
Pembroke Management, LTD | 613,931 | $40,041,000 | 3.36% |
XXEC, Inc. | 52,800 | $3,444,000 | 2.71% |
Global Alpha Capital Management Ltd. | 302,377 | $19,721,000 | 2.42% |
Van Berkom & Associates Inc. | 1,572,303 | $102,546,000 | 2.35% |
PARADIGM CAPITAL MANAGEMENT INC/NY | 581,700 | $37,939,000 | 2.27% |
RTW INVESTMENTS, LP | 1,640,859 | $107,017,000 | 1.80% |